• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血栓调节蛋白启动子基因多态性rs2239562影响脓毒症的易感性和预后。

A Thrombomodulin Promoter Gene Polymorphism, rs2239562, Influences Both Susceptibility to and Outcome of Sepsis.

作者信息

Watanabe Eizo, Takasu Osamu, Teratake Youichi, Sakamoto Teruo, Ikeda Toshiaki, Kotani Joji, Kitamura Nobuya, Ohmori Masaaki, Teratani Ayako, Honda Goichi, Hatano Masahiko, Mayer Benjamin, Schneider E Marion, Oda Shigeto

机构信息

Department of Emergency and Critical Care Medicine, Chiba University Graduate School of Medicine, Chiba, Japan.

General Medical Science, Chiba University Graduate School of Medicine, Chiba, Japan.

出版信息

Front Med (Lausanne). 2022 Jan 10;8:762198. doi: 10.3389/fmed.2021.762198. eCollection 2021.

DOI:10.3389/fmed.2021.762198
PMID:35083232
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8785550/
Abstract

Disseminated intravascular coagulation plays a key role in the pathophysiology of sepsis. Thrombomodulin is essential in the protein C system of coagulation cascade, and functional polymorphisms influence the human thrombomodulin gene (). Therefore, we conducted a multicenter study to evaluate the influence of such polymorphisms on the pathophysiology of sepsis. A collaborative case-control study in the intensive care unit (ICU) of each of five tertiary emergency centers. The study included 259 patients (of whom 125 displayed severe sepsis), who were admitted to the ICU of Chiba University Hospital, Chiba, Japan between October 2001 and September 2008 (discovery cohort) and 793 patients (of whom 271 patients displayed severe sepsis), who were admitted to the five ICUs between October 2008 and September 2012 (multicenter validation cohort). To assess the susceptibility to severe sepsis, we further selected 222 critically ill patients from the validation cohort matched for age, gender, morbidity, and severity with the patients with severe sepsis, but without any evidence of sepsis. We examined whether the eight single nucleotide polymorphisms (SNPs) were associated with susceptibility to and/or mortality of sepsis. Higher mortality on severe sepsis in the discovery and combined cohorts was significantly associated with the CC genotype in a promoter SNP (-1920C/G; rs2239562) [odds ratio [] 2.709 (1.067-6.877), = 0.033 and 1.768 (1.060-2.949), = 0.028]. Furthermore, rs2239562 SNP was associated with susceptibility to severe sepsis [ 1.593 (1.086-2.338), = 0.017]. The data demonstrate that rs2239562, the promoter SNP influences both the outcome and susceptibility to severe sepsis.

摘要

弥散性血管内凝血在脓毒症的病理生理学中起关键作用。血栓调节蛋白在凝血级联反应的蛋白C系统中至关重要,其功能多态性会影响人类血栓调节蛋白基因()。因此,我们开展了一项多中心研究,以评估此类多态性对脓毒症病理生理学的影响。在五个三级急诊中心的重症监护病房(ICU)进行了一项合作病例对照研究。该研究纳入了259例患者(其中125例表现为严重脓毒症),这些患者于2001年10月至2008年9月期间入住日本千叶县千叶大学医院的ICU(发现队列),以及793例患者(其中271例表现为严重脓毒症),这些患者于2008年10月至2012年9月期间入住这五个ICU(多中心验证队列)。为了评估对严重脓毒症的易感性,我们从验证队列中进一步选取了222例危重症患者,这些患者在年龄、性别、发病率和严重程度方面与严重脓毒症患者匹配,但无任何脓毒症证据。我们检查了八个单核苷酸多态性(SNP)是否与脓毒症的易感性和/或死亡率相关。发现队列和合并队列中严重脓毒症患者较高的死亡率与启动子SNP(-1920C/G;rs2239562)中的CC基因型显著相关[比值比[]2.709(1.067 - 6.877), = 0.033和1.768(1.060 - 2.949), = 0.028]。此外,rs2239562 SNP与严重脓毒症的易感性相关[1.593(1.086 - 2.338), = 0.017]。数据表明,启动子SNP rs2239562既影响严重脓毒症的结局,也影响其易感性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7ec/8785550/167090ab865d/fmed-08-762198-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7ec/8785550/a6058ce5e055/fmed-08-762198-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7ec/8785550/2a0edbb87847/fmed-08-762198-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7ec/8785550/167090ab865d/fmed-08-762198-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7ec/8785550/a6058ce5e055/fmed-08-762198-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7ec/8785550/2a0edbb87847/fmed-08-762198-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7ec/8785550/167090ab865d/fmed-08-762198-g0003.jpg

相似文献

1
A Thrombomodulin Promoter Gene Polymorphism, rs2239562, Influences Both Susceptibility to and Outcome of Sepsis.血栓调节蛋白启动子基因多态性rs2239562影响脓毒症的易感性和预后。
Front Med (Lausanne). 2022 Jan 10;8:762198. doi: 10.3389/fmed.2021.762198. eCollection 2021.
2
Thrombomodulin gene polymorphism and the occurrence and prognostic value of sepsis acute kidney injury.血栓调节蛋白基因多态性与脓毒症急性肾损伤的发生及预后价值。
Medicine (Baltimore). 2021 Jul 2;100(26):e26293. doi: 10.1097/MD.0000000000026293.
3
Autophagy-related IRGM polymorphism is associated with mortality of patients with severe sepsis.自噬相关的IRGM基因多态性与严重脓毒症患者的死亡率相关。
PLoS One. 2014 Mar 13;9(3):e91522. doi: 10.1371/journal.pone.0091522. eCollection 2014.
4
A randomized, double-blind, placebo-controlled, Phase 2b study to evaluate the safety and efficacy of recombinant human soluble thrombomodulin, ART-123, in patients with sepsis and suspected disseminated intravascular coagulation.一项随机、双盲、安慰剂对照、2b 期研究,旨在评估重组人可溶性血栓调节蛋白(ART-123)在脓毒症和疑似弥漫性血管内凝血患者中的安全性和疗效。
Crit Care Med. 2013 Sep;41(9):2069-79. doi: 10.1097/CCM.0b013e31828e9b03.
5
Single-Nucleotide Polymorphisms Within the Thrombomodulin Gene (THBD) Predict Mortality in Patients With Graft-Versus-Host Disease.血栓调节蛋白基因(THBD)内的单核苷酸多态性可预测移植物抗宿主病患者的死亡率。
J Clin Oncol. 2014 Oct 20;32(30):3421-7. doi: 10.1200/JCO.2013.54.4056. Epub 2014 Sep 15.
6
Recombinant human soluble thrombomodulin and mortality in sepsis-induced disseminated intravascular coagulation. A multicentre retrospective study.重组人可溶性血栓调节蛋白与脓毒症诱发的弥散性血管内凝血的死亡率。一项多中心回顾性研究。
Thromb Haemost. 2016 Jun 2;115(6):1157-66. doi: 10.1160/TH15-12-0987. Epub 2016 Mar 3.
7
Serum thrombomodulin level relates to the clinical course of disseminated intravascular coagulation, multiorgan dysfunction syndrome, and mortality in patients with sepsis.血清血栓调节蛋白水平与脓毒症患者的弥散性血管内凝血、多器官功能障碍综合征的临床病程及死亡率相关。
Crit Care Med. 2008 Mar;36(3):683-9. doi: 10.1097/CCM.0B013E31816537D8.
8
Recombinant human soluble thrombomodulin in sepsis-induced disseminated intravascular coagulation: a multicenter propensity score analysis.重组人可溶性血栓调节蛋白在脓毒症诱导的弥散性血管内凝血中的作用:一项多中心倾向评分分析。
Intensive Care Med. 2013 Apr;39(4):644-52. doi: 10.1007/s00134-013-2822-2. Epub 2013 Jan 30.
9
Coagulation phenotypes in sepsis and effects of recombinant human thrombomodulin: an analysis of three multicentre observational studies.脓毒症中的凝血表型和重组人血栓调节蛋白的作用:三项多中心观察性研究分析。
Crit Care. 2021 Mar 19;25(1):114. doi: 10.1186/s13054-021-03541-5.
10
Benefit profile of recombinant human soluble thrombomodulin in sepsis-induced disseminated intravascular coagulation: a multicenter propensity score analysis.重组人可溶性血栓调节蛋白在脓毒症诱导的弥散性血管内凝血中的获益情况:一项多中心倾向评分分析
Crit Care. 2015 Mar 3;19(1):78. doi: 10.1186/s13054-015-0810-3.

引用本文的文献

1
Dysregulated haemostasis in thrombo-inflammatory disease.血栓炎症性疾病中的血液失调。
Clin Sci (Lond). 2022 Dec 22;136(24):1809-1829. doi: 10.1042/CS20220208.

本文引用的文献

1
The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2020 (J-SSCG 2020).《2020年日本脓毒症及脓毒性休克管理临床实践指南》(J-SSCG 2020)
Acute Med Surg. 2021 Aug 26;8(1):e659. doi: 10.1002/ams2.659. eCollection 2021 Jan-Dec.
2
Thrombomodulin gene polymorphism and the occurrence and prognostic value of sepsis acute kidney injury.血栓调节蛋白基因多态性与脓毒症急性肾损伤的发生及预后价值。
Medicine (Baltimore). 2021 Jul 2;100(26):e26293. doi: 10.1097/MD.0000000000026293.
3
Recombinant human soluble thrombomodulin in patients with sepsis-associated coagulopathy (SCARLET): an updated meta-analysis.
重组人可溶性血栓调节蛋白治疗脓毒症相关凝血病患者(SCARLET):一项更新的荟萃分析。
Crit Care. 2019 Sep 5;23(1):302. doi: 10.1186/s13054-019-2587-2.
4
Derivation, Validation, and Potential Treatment Implications of Novel Clinical Phenotypes for Sepsis.新型败血症临床表型的推导、验证及潜在治疗意义。
JAMA. 2019 May 28;321(20):2003-2017. doi: 10.1001/jama.2019.5791.
5
Effect of a Recombinant Human Soluble Thrombomodulin on Mortality in Patients With Sepsis-Associated Coagulopathy: The SCARLET Randomized Clinical Trial.重组人可溶性血栓调节蛋白对脓毒症相关性凝血病患者死亡率的影响:SCARLET 随机临床试验。
JAMA. 2019 May 28;321(20):1993-2002. doi: 10.1001/jama.2019.5358.
6
Role of disseminated intravascular coagulation in severe sepsis.弥散性血管内凝血在严重脓毒症中的作用。
Thromb Res. 2019 Jun;178:182-188. doi: 10.1016/j.thromres.2019.04.025. Epub 2019 Apr 26.
7
Thrombocytopenia in the ICU: disseminated intravascular coagulation and thrombotic microangiopathies-what intensivists need to know.重症监护病房中的血小板减少症:弥散性血管内凝血和血栓性微血管病——重症医学专家需要了解的内容
Crit Care. 2018 Jun 13;22(1):158. doi: 10.1186/s13054-018-2073-2.
8
Recombinant Human-Soluble Thrombomodulin Contributes to Reduced Mortality in Sepsis Patients With Severe Respiratory Failure: A Retrospective Observational Study Using a Multicenter Dataset.重组人可溶性血栓调节蛋白可降低严重呼吸衰竭的脓毒症患者的死亡率:一项多中心数据集的回顾性观察研究。
Shock. 2019 Feb;51(2):174-179. doi: 10.1097/SHK.0000000000001148.
9
Pharmacokinetics of Standard- and Reduced-Dose Recombinant Human Soluble Thrombomodulin in Patients with Septic Disseminated Intravascular Coagulation during Continuous Hemodiafiltration.标准剂量与减量重组人可溶性血栓调节蛋白在连续性血液透析滤过治疗脓毒症弥散性血管内凝血患者中的药代动力学
Front Med (Lausanne). 2017 Feb 21;4:15. doi: 10.3389/fmed.2017.00015. eCollection 2017.
10
Pharmacokinetics of recombinant human soluble thrombomodulin in disseminated intravascular coagulation patients with acute renal dysfunction.重组人可溶性血栓调节蛋白在合并急性肾功能不全的弥散性血管内凝血患者中的药代动力学
Thromb Haemost. 2017 May 3;117(5):851-859. doi: 10.1160/TH16-07-0547. Epub 2017 Feb 23.